Approval · Notice of Compliance 36880 · 2026
VARIZIG: Notice of Compliance 36880
Issued February 10, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36880
- Date
- February 10, 2026
- Company
- Ki Biopharma LlcWilmington, Delaware, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph and labelling material
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VARIZIG | Not yet assigned | — |
Medicinal ingredients
- VARICELLA ZOSTER IMMUNOGLOBULIN (HUMAN) 125 UNIT per VIAL